Brevan Howard Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Sell
8,571
-17,367
-67% -$446K ﹤0.01% 1795
2026
Q1
$607K Buy
25,938
+1,386
+6% +$25.1K 0.01% 1186
2025
Q4
$348K Buy
24,552
+8,730
+55% +$165K ﹤0.01% 1296
2025
Q3
$392K Buy
+15,822
New +$353K ﹤0.01% 1415
2025
Q1
– Sell
-6,916
Closed -$274K – 1124
2024
Q4
$274K Sell
6,916
-3,971
-36% -$179K ﹤0.01% 808
2024
Q3
$690K Buy
10,887
+6,541
+151% +$472K ﹤0.01% 584
2024
Q2
$294K Buy
+4,346
New +$303K ﹤0.01% 785
2024
Q1
– Sell
-2,898
Closed -$225K – 967
2023
Q4
$225K Buy
+2,898
New +$215K ﹤0.01% 841

Other funds holding ACHC

Brevan Howard Capital Management's ACHC Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Acadia Healthcare (ACHC) stake by 67% in Q2 2026, selling an estimated $446K and leaving 8,571 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Brevan Howard Capital Management first reported a position in ACHC in Q4 2023 and has held it in 8 quarters since. The position peaked at $690K in Q3 2024. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Brevan Howard Capital Management held 8,571 shares of Acadia Healthcare worth $253K as of Q2 2026.
  • Brevan Howard Capital Management sold 17,367 Acadia Healthcare shares in Q2 2026, an estimated $446K.
  • Acadia Healthcare made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1795 holding.
  • Brevan Howard Capital Management first reported a position in Acadia Healthcare in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Acadia Healthcare position peaked at $690K in Q3 2024.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.